Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Plos One|March 10, 2011
Interferon-α-conditioned human monocytes combine a Th1-orienting attitude with the induction of autologous Th17 responses: role of IL-23 and IL-12Stefano M Santini, Caterina Lapenta, Simona Donati, et al.
Handbook of Experimental Pharmacology|November 26, 2008
IFN-alpha in the generation of dendritic cells for cancer immunotherapyStefano Maria Santini, Caterina Lapenta, Laura Santodonato, et al.
Blood|December 21, 2011
IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processingFrancesca Spadaro, Caterina Lapenta, Simona Donati, et al.
Immunobiology|November 25, 2010
IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activityLaura Lattanzi, Carmela Rozera, Diego Marescotti, et al.
The American Journal of Pathology|April 12, 2002
Type I interferon gene transfer sensitizes melanoma cells to apoptosis via a target activity on mitochondrial functionPaola Matarrese, Luigi Di Biase, Laura Santodonato, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell responseLaura Santodonato, Giuseppina D'Agostino, Roberto Nisini, et al.
Vaccine|April 13, 2011
MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68Eleonora Aricò, Domenica M Monque, Giuseppina D'Agostino, et al.
Cancer Research|January 14, 2010
Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligandsRosa Conforti, Yuting Ma, Yannis Morel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2Grégoire Mignot, Evelyn Ullrich, Mathieu Bonmort, et al.
Cancer Immunology Research|April 7, 2018
Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem CellsLuciano Castiello, Paola Sestili, Giovanna Schiavoni, et al.
Pageof 3